Galectin Therapeutics
GALT
#8074
Rank
NZ$0.27 B
Marketcap
$4.45
Share price
1.48%
Change (1 day)
38.79%
Change (1 year)

Galectin Therapeutics (GALT) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : NZ$0.17 B

According to Galectin Therapeutics's latest financial reports the company's total liabilities are NZ$0.17 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Galectin Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31NZ$84.23 M47.12%
2021-12-31NZ$57.25 M661.57%
2020-12-31NZ$7.51 M76.58%
2019-12-31NZ$4.25 M35.54%
2018-12-31NZ$3.14 M-24.84%
2017-12-31NZ$4.17 M-23.42%
2016-12-31NZ$5.45 M174.31%
2015-12-31NZ$1.98 M-8.36%
2014-12-31NZ$2.17 M-28.28%
2013-12-31NZ$3.02 M50.95%
2012-12-31NZ$2 M-29.34%
2011-12-31NZ$2.83 M-72.72%
2010-12-31NZ$10.4 M52.99%
2009-12-31NZ$6.8 M234.45%
2008-12-31NZ$2.03 M-66.61%
2007-12-31NZ$6.09 M-32.8%
2006-12-31NZ$9.06 M348.89%
2005-12-31NZ$2.01 M43.35%
2004-12-31NZ$1.4 M142.21%
2003-12-31NZ$0.58 M-54.36%
2002-12-31NZ$1.27 M-3.93%
2001-12-31NZ$1.32 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$0.29 B 66.88%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.08 B 509.84%๐Ÿ‡บ๐Ÿ‡ธ USA